stockrowChemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
Follow CHE
Alert me
Chemed Corporation (CHE) Revenue
Chemed Corporation's revenue for fiscal 2025 was $2.5B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $2.7B. Over the past ten years it has ranged from $1.5B (fiscal 2015) to $2.5B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 3 consecutive fiscal years. Chemed Corporation ranks 19th of 47 Medical Care Facilities companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $2.5B | 4.06% |
| FY2024 | $2.4B | 7.37% |
| FY2023 | $2.3B | 6.06% |
| FY2022 | $2.1B | (0.20%) |
| FY2021 | $2.1B | 2.87% |
| FY2020 | $2.1B | 7.27% |
| FY2019 | $1.9B | 8.75% |
| FY2018 | $1.8B | 6.96% |
| FY2017 | $1.7B | 5.70% |
| FY2016 | $1.6B | 2.17% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $690.9M | 2.63% |
| Jun 2026 | $673.3M | 2.39% |
| Mar 2026 | $657.5M | 2.84% |
| Dec 2025 | $639.3M | 2.31% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | $22.6B |
| UHS Universal Health Services, Inc. compare | $18.4B |
| DVA DaVita Inc. compare | $14.2B |
| OPCH Option Care Health, Inc. compare | $5.8B |
| PACS PACS Group, Inc. compare | $5.7B |
| ENSG The Ensign Group, Inc. compare | $5.7B |
| CHE Chemed Corporation | $2.7B |
| CON Concentra Group Holdings Parent, Inc. compare | $2.3B |
| LFST LifeStance Health Group, Inc. compare | $1.7B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on CHE
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement